Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 May-Jun;97(3):275-283.
doi: 10.1016/j.abd.2021.05.016. Epub 2022 Mar 18.

Immunobiologicals in dermatology

Dimitri Luz Felipe da Silva  1 , Elisa Nunes Secamilli  2 , Mariana Valbon Beleli  2 , Juliana Yumi Massuda  2 , Andrea F E C Franca  2 , Renata F Magalhães  2
Affiliations

Immunobiologicals in dermatology

Dimitri Luz Felipe da Silva et al. An Bras Dermatol. 2022 May-Jun.

Abstract

Immunobiologicals are a reality in current clinical practice and have increasingly gained space in the inflammatory disease scenario, especially in dermatology, with approved drugs for psoriasis, atopic dermatitis, and hidradenitis suppurativa, in addition to many others undergoing study. It is important for dermatologists to have knowledge of the medications approved in Brazil, for the best management of dermatoses, in addition to the fact that they represent hope for improvement in patients with chronic diseases.

Keywords: Arthritis, psoriatic; Dermatitis, atopic; Hidradenitis suppurativa; Psoriasis.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

References

    1. Yamada T. Therapeutic monoclonal antibodies. Keio J Med. 2011;60:37–46. - PubMed
    1. Robinson D.K., Sethuraman N. How innovative technology is moving biologics into the 21st century. Clin Pharmacol Ther. 2010;87:261–263. - PubMed
    1. Chebli J.M.F., Gaburri P.D., Chebli L.A., Ribeiro T.C.R., Pinto A.L.T., Ambrogini Júnior O., et al. A guide to prepare patients with inflammatory bowel diseases for anti-TNF-α therapy. Med Sci Monit. 2014;20:487–498. - PMC - PubMed
    1. Kurschat P., Rubbert A., Poswig A., Scharffetter-Kochanek K., Krieg T., Hunzelmann N. Treatment of psoriatic arthritis with etanercept. J Am Acad Dermatol. 2001;44:1052. - PubMed
    1. Melsheimer R., Geldhof A., Apaolaza I., Schaible T. Remicade® (infliximab): 20 years of contributions to science and medicine. Biologics. 2019;13:139–178. - PMC - PubMed